Outcomes of Patients With Peripartum Cardiomyopathy Who Received Mechanical Circulatory Support

Circulation: Heart Failure - Tập 7 Số 2 - Trang 300-309 - 2014
Renzo Y. Loyaga‐Rendon1,2, Salpy V. Pamboukian1,2, José Tallaj1,2, Deepak Acharya1,2, Ryan S. Cantor1,2, Randall C. Starling1,2, David C. Naftel1,2, James K. Kirklin1,2
1From the Cardiovascular Diseases Division (R.Y.L.-R., S.V.P., J.A.T., D.A.), Cardiothoracic Surgery Division (R.C., J.K., DN), Department of Epidemiology, School of Public Health (R.C.), University of Alabama at Birmingham; and Section of Heart Failure, Cleveland Clinic Foundation, OH (R.C.S.).
2Section of Heart Failure, Cleveland Clinic Foundation, OH (R.C.S.).

Tóm tắt

Background— We describe the characteristics and outcomes of peripartum cardiomyopathy (PPCMP) patients who received durable mechanical circulatory support and compared it with other etiologies of advanced heart failure. Methods and Results— We analyzed 1258 women who were registered in Interagency Registry for Mechanically Assisted Circulatory Support between June 2006 and March 2012. Baseline characteristics, implant strategies, hemodynamics, echocardiographic data, and outcomes were compared. Ninety-nine women had PPCMP and 1159 had non-PPCMP as primary diagnosis. PPCMP women were younger ( P <0.001), more likely to be blacks, and had less comorbidities than non-PPCMP patients. PPCMP women had better survival than non-PPCMP women ( P =0.01) with a 2-year survival of 83%. Multivariable risk factor adjustment analysis showed that the improved survival was likely because of younger age and fewer comorbidities. At 36 months, a proportion of 48% PPCMP received heart transplantation. Recovery occurred at a frequency of 6% and 2% in the PPCMP and non-PPCMP groups ( P =0.1). Adverse event rates were similar in PPCMP and non-PPCMP patients except for higher cardiac arrhythmias and respiratory failure in the non-PPCMP in the first 3 months post implant. Conclusions— PPCMP women who receive durable mechanical circulatory support have a better survival than women with non-PPCPM. The improved survival observed in PPCMP is likely related to their fewer comorbidities and younger age. Myocardial recovery was uncommon and less than half of women with end-stage PPCPM received heart transplantation after 3 years of mechanical support.

Từ khóa


Tài liệu tham khảo

10.1016/j.jacc.2011.03.047

10.1097/AOG.0b013e318229e6de

10.1016/j.amjcard.2006.01.039

10.1016/j.amjcard.2007.02.092

10.1097/AOG.0b013e31826e46a1

10.1093/eurjhf/hfq120

10.1016/j.cardfail.2011.09.009

10.1016/j.ahj.2006.02.008

10.1093/eurjhf/hfs070

10.1016/j.ajog.2009.04.037

10.1016/j.healun.2011.11.018

10.1016/j.athoracsur.2009.12.064

10.1186/1749-8090-6-150

10.1186/cc10098

McGiffin DC, Naftel DC, Kirklin JK, Morrow WR, Towbin J, Shaddy R, Alejos J, Rossi A. Predicting outcome after listing for heart transplantation in children: comparison of Kaplan-Meier and parametric competing risk analysis. Pediatric Heart Transplant Study Group. J Heart Lung Transplant. 1997;16:713–722.

10.1080/01621459.1986.10478314

10.1016/j.healun.2012.12.004

10.1016/j.cardfail.2013.03.004

10.1016/j.healun.2009.02.015

Cleveland JC, Naftel DC, Reece TB, Murray M, Antaki J, Pagani FD, Kirklin JK. Survival after biventricular assist device implantation: an analysis of the Interagency Registry for Mechanically Assisted Circulatory Support database. J Heart Lung Transplant. 2011;30:862–869.

10.1016/j.jacc.2010.10.062

10.1016/j.healun.2010.08.007

10.1016/j.cardfail.2012.08.001

10.1016/j.cardfail.2012.01.020

10.1056/NEJMoa053063

10.1007/BF03086192

10.1016/j.ejheart.2008.07.005

10.7150/ijms.6219

10.1016/j.cell.2006.12.036

10.1161/CIRCULATIONAHA.109.901496

10.1016/j.athoracsur.2010.06.110

10.1007/s00392-012-0494-5

10.1161/CIRCULATIONAHA.109.931220